Skip to content

Tennis Injury Prevention: the KNLTB Tennisready ApP (TIPTAP) Trial

Tennis Injury Prevention: the KNLTB Tennisready ApP (TIPTAP) Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON21419
Enrollment
658
Registered
2017-04-11
Start date
2017-04-14
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sports injuries

Interventions

KNLTB TennisReady consists of a structural on and off court program specific for tennis players. It is made available for those participants randomised to the TennisReady group. THey are encouraged to

Sponsors

AMC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. age of ≥ 18 years 2. own a smartphone or tablet 3. willingness to perform the TennisReady program at least twice per week (off and/or on-court)

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
otal acute and overuse injury prevalence (in percentage) during follow up

Secondary

MeasureTime frame
1. Location specific injury prevalence (in percentage) during follow up with locations defined according to the definitions by Pluim et al 3(see tables 2 and 3) 2. Injury rate during follow up defined as the total number of injuries per 1000 player hours. 3. Injury rate (injuries/1000 playing hours) with injury type and location subdivision according to Pluim et al.3 4. Severity defined as time to return to play in days for injured players. Time to return to play is defined as the time from the start of injury until full and unrestricted return to recreational tennis play. 5. Acute Injury recurrence rate for injured players within 2, 6 and 12 months. 6. Self-reported compliance defined as the self-reported use of KT. 7. Monthly self-reported Coach compliance to the program defined as the self-reported percentage of training sessions that the KTAP warm up was used.

Contacts

Public ContactHaiko Pas
h.i.pas@amc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)